T0	Limitation 32862 32867	While
T1	Limitation 33144 33147	Our
T2	Limitation 37202 37205	The
T3	Limitation 38181 38183	We
T4	Limitation 38366 38379	Additionally,
T5	UnderpoweredStudy 33102 33142	study was not powered for these analyses
T6	Population 33144 33209	Our patients presented relatively late after the onset of illness
T7	Population 37202 37246	The heterogeneous population characteristics
T8	UnderpoweredStudy 38288 38305	power was limited
T9	SampleSize 38241 38281	subgroup analyses involved small numbers
T10	ActivePlacebo 38383 38434	all patients were randomised to an active treatment
